New Delhi, India – 110 016

Soliqua Solostar (Insulin Glargine+Lixisenatide) available Delhi, Mumbai, Madras, Hyderabad, Bangalore India

Soliqua Solostar (Insulin Glargine + Lixisenatide) Injection

Generic brands for Insulin Glargine + Lixisenatide Injection Available in India

Brand Name Soliqua Solostar
Generic Name Insulin Glargine + Lixisenatide

 
Strength
Manufacturer Sanofi India Ltd

 

Description

Description

This page contains brief details about the drug insulin glargine,lixisenatide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

The FDA approved Insulin glargine, Lixisenatide for medical use on 21st, Nov 2016 for Type 2 diabetes.

A 2022 study evaluated the efficacy of Insulin Glargine and Lixisenatide in adults with type 2 diabetes. The study found that Insulin Glargine and Lixisenatide significantly improved glycemic control by reducing HbA1c levels without causing weight gain. Additionally, the study reported a low risk of hypoglycemia.

Mechanism of Action of Insulin Glargine + Lixisenatide 

The Insulin glargine in the medicine, helps to lower the blood glucose level by replacing the insulin which is normally produced in our body.  The Lixisenatide is an GLP-1 agonist, which stimulates the release of insulin during the hyperglycemia (high blood glucose level).

Uses of Insulin Glargine + Lixisenatide 

Insulin glargine, Lixisenatide, is used to control blood sugar levels and elevate the production of insulin in the body. It also helps to slow down glucose absorption from foods. It aids in treating type 2 diabetes in adults and controls blood sugar when it becomes abnormal. If other medicines fail to treat or control high blood glucose levels, Insulin glargine, Lixisenatide can be given along with metformin and/or sodium-glucose co-transporter-2 (SGLT2) inhibitors.

We can ship to :

News/Updates

References

  1. Sanofi-Aventis Deutschland GmbH, European Medicines Agency (EMA), [Revised on 18 July 2024] [Accessed on 21 May 2024], Suliqua, INN-insulin glargine+lixisenatide (europa.eu)
  2. Sanofi-aventis, US Food and Drug Administration, FDA [Revised on July 2021] [Accessed on 21st May 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208673s013lbl.pdf
  3. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Hormones and Hormones Antagonists, 13th edition, 2011, 871 & 877.
  4. Candido, R., Modugno, M., Larosa, M. et al. Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study. Diabetes Ther 14, 77–92 (2023). https://doi.org/10.1007/s13300-022-01328-7
Categories , , , Tag

Related products

Frequently Asked Questions

South Delhi Pharma is a consultancy company which facilitates patients, hospitals, clinicians and researchers in accessing products which are not available or approved in their home country. IPN also helps companies in designing and implementing PAP (Patient Assistance Plan) or Patient Centric Programs, CROs in accessing products for clinical trials. More Details

South Delhi Pharma 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India) Email: [email protected]

There are several ways through which we can be contacted. Mobile: We can be reached on +91-9891296838 ( 9am – 6pm IST, on working days) Email: Please send your enquires directly to [email protected]. We will respond within 1 working days after receiving your mail. Please mention your detail enquiry & contact details with ISD code in your email. For otherwise urgent requirement, we can be reached through email [email protected] during closing hours. We will respond within 2 hours provided you submit your detailed enquiry & contact number with ISD Code.

Website: You can visit our website and fill in enquiry form mentioned on the website. We will respond within 1 working days after receiving your query form. Office: You can visit our office during working hours if you are in Delhi NCR. South Delhi Pharma 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India).

Images shown on website are sometimes taken from image released by manufacturing company specific to country/Region. Over period of time they go through some minor makeover depending on regulatory changes, country specific, language specific or batch variations. This sometime not possible to cover all variations on website. However, we assure genuine sourcing for all our products which are supplied using The Indian Pharma services

Medicines once shipped will not be taken back. We will assist you with the Export Invoice and tracking details of your order. International orders might be subject to import taxes/duties. For information, please contact your local customs authority. Any such taxes are the responsibility of the parcel recipient and are not paid by us.

There are some medicines which have been approved recently in USA or Europe but not yet approved in India or any other countries are not permitted to be imported or marketed commercially. However, they may be required for the treatment of patients to save their lives who have exhausted all other available treatment options in their country. Named – Patient Program is to facilitate import of such medicines for personal use. There is a provision under the Indian Drugs and Cosmetics Rules, 1945, that permits the patient to import these medicine in small quantity. Similar regulatory provision also exist in other countries. We assist patient in preparing legal documents for import and connecting them with authorized suppliers in USA and Europe to secure genuine products.

A generic drug is a drug defined as “a drug product that is comparable to a brand/reference listed drug product in dosage form, strength, quality and performance characteristics, and intended use”. There are Indian companies which manufacture and market these generic medicines after getting approval from Regulatory Authority of the country. These generic medicines contain the same active ingredients as the original formulation and are identical or within an acceptable bioequivalent range to the Innovator drug counterpart with respect to pharmacokinetic and pharmaco-dynamic properties. By extension, therefore, generics are considered identical in dose, strength, route of administration, safety, efficacy, and intended use. They are labeled with the name of the manufacturer and the adopted name (nonproprietary name) of the drug. When generic products become available, the market competition often leads to substantially lower prices and thereby make is affordable for large number of needy patients.

It usually takes 8-9 working days after dispatch to reach medicine at outside India locations. Additional delays may occur due to heavy load on postal services and customs.

We advise to transfer money only through Interbank Transfer Modalities;

  • Online Net-banking for within India transfer.
  • International Wire Transfer (SWIFT) from outside India.
  • Cash on Delivery within India.

Cash on Delivery (COD) option is only available if the medicine is purchased and delivered in India. Preferred locations within India for COD facilities are within Municipal limits of New Delhi & NCR, Mumbai, Bangalore, Kolkata, Chennai & Hyderabad

Customer Reviews

“A review from a customer who benefited from your product. Reviews can be a highly effective way of establishing credibility and increasing your company's reputation.”
Customer Name
“A review from a customer who benefited from your product. Reviews can be a highly effective way of establishing credibility and increasing your company's reputation.”
Customer Name
“A review from a customer who benefited from your product. Reviews can be a highly effective way of establishing credibility and increasing your company's reputation.”
Customer Name